As PSG9 is a secreted glycoprotein, it is interesting to carry out a population‐based cohort study to examine the possibility of PSG9 as a potential plasma biomarker for the prediction and/or prognosis of breast cancer. Here, PSG9 is linked to breast carcinoma.